Wendy Blosser
Directeur Général chez ACCUSTEM SCIENCES, INC.
Fortune : 940 $ au 31/05/2024
Postes actifs de Wendy Blosser
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACCUSTEM SCIENCES, INC. | Directeur/Membre du Conseil | 04/03/2022 | - |
| Directeur Général | 04/03/2022 | - | |
| Investor Relations Contact | 04/03/2022 | - |
Historique de carrière de Wendy Blosser
Anciens postes connus de Wendy Blosser
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Corporate Officer/Principal | 01/05/2019 | 01/03/2021 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - | - |
| Integrated Oncology Solutions, Inc. | Sales & Marketing | - | - |
| BIODESIX, INC. | Corporate Officer/Principal | - | - |
Formation de Wendy Blosser
| Marietta College | Undergraduate Degree |
| West Virginia University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Pays-Bas | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIODESIX, INC. | Health Services |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Integrated Oncology Solutions, Inc. | |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
- Bourse
- Insiders
- Wendy Blosser
- Expérience
